Publications by authors named "Daqi Deng"

Claim this Profile
T
Tracking non-genetic evolution from primary to metastatic ccRCC: TRACERx Renal.
Ángel Fernández-Sanromán, Annika Fendler, Benjy J Y Tan, Anne-Laure Cattin, Charlotte Spencer, Daqi Deng

Cancer Discov· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tracking Nongenetic Evolution from Primary to Metastatic ccRCC: TRACERx Renal.
Ángel Fernández-Sanromán, Annika Fendler, Benjy J Y Tan, Anne-Laure Cattin, Charlotte Spencer, Daqi Deng

Cancer Discov· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation of TWO iPSC lines (CRICKi009-A; CRICKi010-A) from patients with type 1 von Hippel-Lindau (VHL) and histopathologically confirmed renal cell carcinoma (RCC).
Liani G Devito, Eugénie S Lim, Samuel M O'Toole, Scott T C Shepherd, Daqi Deng

Stem Cell Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single cell multi-omics reveal intra-cell-line heterogeneity across human cancer cell lines.
Qionghua Zhu, Xin Zhao, Yuanhang Zhang, Yanping Li, Shang Liu, Daqi Deng

Nat Commun· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ActuAtor, a Listeria-inspired molecular tool for physical manipulation of intracellular organizations through de novo actin polymerization.
Hideki Nakamura, Elmer Rho, Christopher T Lee, Kie Itoh, Daqi Deng

Cell Rep· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancer.
Mary Y Wu, Scott T C Shepherd, Annika Fendler, Edward J Carr, Lewis Au, Daqi Deng

Cancer Cell· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancer.
Annika Fendler, Scott T C Shepherd, Lewis Au, Mary Wu, Ruth Harvey, Daqi Deng

Cell Rep Med· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer.
Annika Fendler, Scott T C Shepherd, Lewis Au, Katalin A Wilkinson, Mary Wu, Daqi Deng

Cancer Cell· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer.
Annika Fendler, Scott T C Shepherd, Lewis Au, Mary Wu, Ruth Harvey, Daqi Deng

Lancet· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer.
Annika Fendler, Scott T C Shepherd, Lewis Au, Katalin A Wilkinson, Mary Wu, Daqi Deng

Cancer Cell· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: The CAPTURE study.
Annika Fendler, Scott T C Shepherd, Lewis Au, Katalin A Wilkinson, Mary Wu, Daqi Deng

Nat Cancer· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study.
Annika Fendler, Scott T C Shepherd, Lewis Au, Katalin A Wilkinson, Mary Wu, Daqi Deng

Nat Cancer· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CIGAR-seq, a CRISPR/Cas-based method for unbiased screening of novel mRNA modification regulators.
Liang Fang, Wen Wang, Guipeng Li, Li Zhang, Jun Li, Daqi Deng

Mol Syst Biol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative multi-omics analysis of a colon cancer cell line with heterogeneous Wnt activity revealed RUNX2 as an epigenetic regulator of EMT.
Hongyang Yi, Guipeng Li, Yongkang Long, Weizheng Liang, Huanhuan Cui, Daqi Deng

Oncogene· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis